Zistaroo Danesh Company

Zist Aru Danesh is an Iranian biotechnology company specializing in the development and production of biosimilar pharmaceutical products. The company focuses on high-value recombinant proteins and monoclonal antibodies for the treatment of chronic and life-threatening conditions such as osteoporosis, cancer, and autoimmune disorders. Operating out of the Pardis Technology Park, Zist Aru Danesh utilizes advanced bioprocessing technologies to manufacture products like Teriparatide and Rituximab. The firm aims to increase accessibility to essential biologic medicines within the Middle East and North Africa (MENA) region through local production and strategic exports. Zist Aru Danesh maintains state-of-the-art manufacturing facilities that comply with international Good Manufacturing Practice (GMP) standards. By leveraging local expertise in bioprocessing, the company plays a critical role in the Iranian pharmaceutical landscape.